The Cervical Cancer Treatment Gap in Mexico Under

Cervical cancer Mexico Seguro Popular healthcare financing treatment gap

Journal

Health systems and reform
ISSN: 2328-8620
Titre abrégé: Health Syst Reform
Pays: United States
ID NLM: 101697320

Informations de publication

Date de publication:
31 Dec 2023
Historique:
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

From 2005 to 2019, the Mexican government financed cervical cancer treatment for individuals without social security insurance through

Identifiants

pubmed: 37944505
doi: 10.1080/23288604.2023.2272371
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2272371

Auteurs

Sean P McClellan (SP)

Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.

Karla Unger-Saldaña (K)

Epidemiology Research Unit, National Institute of Cancer, Mexico City, Mexico.

Priscilla Espinosa-Tamez (P)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Erick Suazo-Zepeda (E)

Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.

Michael B Potter (MB)

Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.

Salim Abraham Barquet-Muñoz (SA)

Department of Gynecology, National Institute of Cancer, Mexico City, Mexico.

Leticia Torres-Ibarra (L)

Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.

Hector Lamadrid-Figueroa (H)

Department of Perinatal Health, National Institute of Public Health, Cuernavaca, Mexico.

Martín Lajous (M)

Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH